Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL1264751 | 1.00 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL20656 | 0.96 | TSHR (0.43) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL27551504 | 0.96 | TSHR (0.43) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL7549527 | 0.96 | TSHR (0.43) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| Hydrogen Sulfide SCHEMBL9281216 | 0.92 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| Bromide SCHEMBL10582038 | 0.92 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| Water SCHEMBL1155699 | 0.92 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL22204469 | 0.92 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL809934 | 0.92 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL3429854 | 0.92 | TSHR (0.40) | TSHRALDH1A1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336851-B2 | Copolymer for semiconductor lithography, resist composition, and method for manufacturing substrate | MITSUBISHI CHEMICAL CORPORATION | 2019-07-02 | — | — | US | disclosed |
| EP-2302000-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-20160200849-A1 | COPOLYMER FOR SEMICONDUCTOR LITHOGRAPHY, RESIST COMPOSITION, AND METHOD FOR MANUFACTURING SUBSTRATE | MITSUBISHI RAYON CO., LTD. (JP) | 2016-07-14 | — | — | US | disclosed |
| US-9051501-B2 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| US-8558108-B2 | Electron donating material, material for photovoltaic devices and photovoltaic device | TORAY INDUSTRIES, INC. (JP) | 2013-10-15 | — | — | US | disclosed |
| EP-2266982-B1 | ELECTRON DONATING ORGANIC MATERIAL, MATERIAL FOR PHOTOVOLTAIC ELEMENT, AND PHOTOVOLTAIC ELEMENT | TORAY INDUSTRIES (JP) | 2013-09-04 | — | — | EP | disclosed |
| EP-2088173-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2012-02-22 | — | — | EP | disclosed |
| EP-2302000-A1 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20110023964-A1 | ELECTRON DONATING MATERIAL, MATERIAL FOR PHOTOVOLTAIC DEVICES AND PHOTOVOLTAIC DEVICE | TORAY INDUSTRIES, INC. (JP) | 2011-02-03 | — | — | US | disclosed |
| EP-2266982-A1 | ELECTRON DONATING ORGANIC MATERIAL, MATERIAL FOR PHOTOVOLTAIC ELEMENT, AND PHOTOVOLTAIC ELEMENT | Toray Industries, Inc. (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20100041810-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2088173-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | Kaneka Corporation (JP) | 2009-08-12 | — | — | EP | disclosed |
| EP-1295602-A1 | OXYGEN-CONTAINING OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-20020164379-A1 | Oxygen-containing ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-0282973-B1 | CROSS-LINKING OF THERMOSETTING RESINS BY MEANS OF HEATING WITH SATURATED PERFLUOROPOLYETHER VAPOUR | AUSIMONT S.r.l. (IT) | 1991-05-29 | — | — | EP | disclosed |
| EP-0282973-A1 | Cross-linking of thermosetting resins by means of heating with saturated perfluoropolyether vapour | AUSIMONT S.r.l. (IT) | 1988-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020164379-A1 | Oxygen-containing ophthalmic composition | OGFOD1, HIF1A, HAO2 | TSHR 4566/4885ALDH1A1 1873/4885OPRM1 862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.